Emisphere's Eligen® Technology binds a delivery agent with a therapeutic compound without alternation. This process occurs when both agent and compound are in close proximity.
After oral ingestion, the drug-carrier combination comes in contact with stomach/intestinal membrane. Delivery agent chaperones compound through the gastrointestinal (GI) membrane, with weak intermolecular forces allowing for separation.
Download to find out more.